Seegene, Inc.
Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MDx). Seegene’s core enabling technologies, DPO™, TOCE™, and MuDT™, are the foundations for multiplex molecular diagnostics and companion diagnostic tests. With the core technologies applied, Seegene provides high sensitivity, specificity, and reproducibility tests. Seegene’s products can simultaneously detect and identify minority species and quantitate multiple targets. They can also detect multi pathogens with great reliability and throughput, which enables more efficient testing by saving time, labor, and cost. Seegene’s mission is to maintain leadership in molecular diagnostics in the fields of infectious diseases, genetics, pharmacogenetics, and oncology using innovative proprietary technologies.
Additional Info
Included in the Export Interest Directory?
YesBusiness Needs:
Distributor/Agent/Representative, Joint Ventures, Other